MAPT and Atrophy: Whilst we failed to find an association between any analyte and rate of atrophy in the amyloid negative group, after allowance for multiple comparisons in the amyloid-positive group in which we adjusted for baseline brain volume and t-tau, we found that 45 analytes predicted increased ventricular expansion and ten predicted rate of whole brain atrophy.